Complex High-Risk Coronary Intervention with Percutaneous Ventricular Support: An Analysis of Complete vs Target Lesion Revascularization
Behnam N. Tehrani, M.D.1, Abdulla A Damluji, MD, PhD, MPH2, Carolyn M. Rosner, MSN, RN, FNP-BC3, Siqi Wei4, James Park, BS2, Hooman Bakhshi, MD2, Nicholas Balaji, M.D.5, Nicholas Cossa6, Christopher R Defilippi, M.D.7, Kelly Epps, M.D.8, Edward W. Howard, M.B.B.S.9, Nadim A. Geloo, M.D., FSCAI10, Joseph M. Kiernan III, M.D., FSCAI11, Mitchell Psotka, MD, PhD, MPH2, Narian Rajan, MD2, Matthew W. Sherwood, M.D., FSCAI12, Shashank Sinha, MD, MSc7, Rahsaan Smith, MD2, Eugene K. Soh, M.D.13, Hamid Taheri, M.D.14, Alexander G. Truesdell, M.D., FSCAI15, Shahram Yazdani, M.D.16 and Wayne B. Batchelor, M.D., FSCAI12, (1)Inova Heart and Vascular Institute, Oakton, VA, (2)INOVA Heart and Vascular Institute, Falls Church, VA, (3)Inova Fairfax Hospital, Falls Church, VA, (4)George Mason University, Fairfax, VA, (5)The Heart Center of Northeast Georgia Medical Center, Falls Church, VA, (6)Virginia Heart / INOVA Heart and Vascular Institute, Mclean, VA, (7)Inova Health System, Falls Church, VA, (8)Inova Fairfax Hospital, Washington, DC, (9)Virginia Heart, Annandale, VA, (10)Abbott, Fairfax, VA, (11)Virginia Heart, Vienna, VA, (12)Inova Fairfax Hospital, McLean, VA, (13)Carient Heart and Vascular, Manassas, VA, (14)Inova Fairfax Hospital, Mclean, VA, (15)Virginia Heart / Inova Schar Heart and Vascular Institute, Mclean, VA, (16)Virginia Cardiovascular Associates, Mc Lean, VA